|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||144.08 - 145.44|
|52 Week Range||106.48 - 148.84|
|PE Ratio (TTM)||32.42|
|Dividend & Yield||1.70 (1.17%)|
|1y Target Est||N/A|
Accuray's (ARAY) Radixact system leverages on its flagship TomoTherapy platform. The company's top-line growth is dependent on TomoTherapy system sales.
Positive tidings on the regulatory front have favored Globus Medical (GMED) of late. The company's latest regulatory progress would lend it a competitive edge in the global niche space.
Army personnel recently traveled from Germany to the Aberdeen Proving Ground in Maryland for...